Surgery Partners (NASDAQ:SGRY) Price Target Raised to $25.00

Surgery Partners (NASDAQ:SGRY) had its price target increased by TD Cowen from $23.50 to $25.00 in a research report report published on Wednesday,Benzinga reports. TD Cowen currently has a hold rating on the stock.

Several other brokerages also recently commented on SGRY. Mizuho downgraded shares of Surgery Partners from an “outperform” rating to a “neutral” rating and boosted their price objective for the company from $19.00 to $25.00 in a research report on Wednesday. Cantor Fitzgerald downgraded Surgery Partners from an “overweight” rating to a “hold” rating in a report on Monday, October 26th. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Raymond James Financial set a $23.50 price target on Surgery Partners in a report on Monday, October 26th. Finally, Royal Bank Of Canada boosted their price target on Surgery Partners from $23.50 to $25.00 and gave the stock a “sector perform” rating in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $20.70.

Surgery Partners Stock Performance

NASDAQ SGRY opened at $26.95 on Wednesday. The firm has a 50-day moving average price of $17.30 and a two-hundred day moving average price of $15.10. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $27.23. The company has a market capitalization of $3.53 billion, a P/E ratio of 126.57 and a beta of 1.85. The company has a quick ratio of 1.78, a current ratio of 2.17 and a debt-to-equity ratio of 1.03.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, November 9th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $815.30 million during the quarter, compared to the consensus estimate of $820.96 million. Surgery Partners had a positive return on equity of 0.98% and a negative net margin of 2.59%. The company’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.13 EPS. Analysts anticipate that Surgery Partners will post 0.07 earnings per share for the current year.

Insiders Place Their Bets

In other Surgery Partners news, Director Teresa DeLuca acquired 10,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, with a total value of $143,500.00. Following the purchase, the director owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.00% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

Hedge funds have recently added to or reduced their stakes in the business. Swiss National Bank lifted its stake in Surgery Partners by 1.1% in the first quarter. Swiss National Bank now owns 153,500 shares of the company’s stock valued at $1,830,000 after buying an additional 1,700 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of Surgery Partners by 239.6% during the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after acquiring an additional 2,051 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Surgery Partners during the second quarter worth about $38,000. Fifth Third Bancorp increased its holdings in shares of Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after acquiring an additional 3,993 shares during the period. Finally, Inspire Investing LLC increased its holdings in shares of Surgery Partners by 10.1% in the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock worth $621,000 after acquiring an additional 4,099 shares during the period.

About Surgery Partners

Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.